162 related articles for article (PubMed ID: 3771260)
1. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients.
Jeevanram RK; Shah DH; Sharma SM; Ganatra RD
Int J Rad Appl Instrum B; 1986; 13(3):277-9. PubMed ID: 3771260
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.
Bal CS; Kumar A; Pant GS
Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045
[TBL] [Abstract][Full Text] [Related]
3. High or low dose radioiodine ablation of thyroid remnants?
Creutzig H
Eur J Nucl Med; 1987; 12(10):500-2. PubMed ID: 3569338
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
[TBL] [Abstract][Full Text] [Related]
5. [Indications for adjuvant therapy of thyroid cancer with radioiodine therapy].
Jarzab B
Wiad Lek; 2001; 54 Suppl 1():254-65. PubMed ID: 12182034
[TBL] [Abstract][Full Text] [Related]
6. Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET.
O'Connell ME; Flower MA; Hinton PJ; Harmer CL; McCready VR
Radiother Oncol; 1993 Jul; 28(1):16-26. PubMed ID: 8234866
[TBL] [Abstract][Full Text] [Related]
7. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
8. A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy.
Bal CS; Kumar A; Chandra P; Dwivedi SN; Pant GS
Acta Oncol; 2006; 45(8):1067-72. PubMed ID: 17118841
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome.
Logue JP; Tsang RW; Brierley JD; Simpson WJ
Br J Radiol; 1994 Nov; 67(803):1127-31. PubMed ID: 7820407
[TBL] [Abstract][Full Text] [Related]
10. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates.
Karam M; Gianoukakis A; Feustel PJ; Cheema A; Postal ES; Cooper JA
Nucl Med Commun; 2003 May; 24(5):489-95. PubMed ID: 12717064
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.
Ceccarelli C; Battisti P; Gasperi M; Fantuzzi E; Pacini F; Gualdrini G; Pierantoni MC; Luciani A; Djokich D; Pinchera A
J Nucl Med; 1999 Oct; 40(10):1716-21. PubMed ID: 10520714
[TBL] [Abstract][Full Text] [Related]
12. Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy.
de Klerk JM; de Keizer B; Zelissen PM; Lips CM; Koppeschaar HP
Nucl Med Commun; 2000 Jun; 21(6):529-32. PubMed ID: 10894561
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of low dose irradiation with 131 Iodine after thyroidectomy and before iodine radiotherapy in patients with differentiated carcinoma of the thyroid].
Rosário PW; Barroso AL; Padrão EL; Rezende LL; Purisch S
Arq Bras Endocrinol Metabol; 2004 Apr; 48(2):324-5. PubMed ID: 15640891
[No Abstract] [Full Text] [Related]
14. [Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].
Günter HH; Junker D; Schober O; Hundeshagen H
Strahlenther Onkol; 1987 Mar; 163(3):185-91. PubMed ID: 3563879
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Ramanna L; Waxman AD; Brachman MB; Tanasescu DE; Sensel N; Braunstein GD
Clin Nucl Med; 1985 Nov; 10(11):791-5. PubMed ID: 4075672
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery.
Samuel AM; Rajashekharrao B
J Nucl Med; 1994 Dec; 35(12):1944-50. PubMed ID: 7989975
[TBL] [Abstract][Full Text] [Related]
17. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
[TBL] [Abstract][Full Text] [Related]
18. Treatment of medullary carcinoma of the thyroid with I-131.
Nusynowitz ML; Pollard E; Benedetto AR; Lecklitner ML; Ware RW
J Nucl Med; 1982 Feb; 23(2):143-6. PubMed ID: 7057256
[TBL] [Abstract][Full Text] [Related]
19. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
[TBL] [Abstract][Full Text] [Related]
20. [Lithium as an adjuvant in the radioiodine therapy of thyroid cancer].
Schraube P; Kimmig B; zum Winkel K
Nuklearmedizin; 1984 Jun; 23(3):151-4. PubMed ID: 6435095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
